Login
Toggle navi gation
MENU
MENU
About
BioUtah Mission-Vision
Our Team
Governance
Board of Directors
Advisory Board
Elite Members
Partnerships
Membership
Member Login
Why BioUtah?
Member Deals
Apply for Membership
Membership Directory
Advocacy
News/Events
Events
Life Sciences News
Podcasts
Why Utah?
Life Sciences Report
Life Sciences Leadership
Investment
Newsletter
BioHive
About BioUtah
BioUtah Mission-Vision
Board Members
Our Team
Sponsors
Who Are We
Advisory Board
Advocacy
Annual Legislative Luncheon
BIO Business Solutions
BIO Business Solutions
BioHive
COVID-19 Resources
Business Resources
COVID-19 Events
COVID-19 Federal News
COVID-19 State News
HHS/FDA News
Utah’s Life Sciences Companies
Workplace Safety
Events
Generic Integration Page
Governance
Committees
Index
BioUtah Summary Overview
Slide 1
Slide 2
Investment
Jobs
Member Login
Membership Application
Membership Levels
Member Deals
Member Information
Membership Directory
Memberzone
Networking
Newsletter
Partnerships
RAPS Utah
Sitemap
Sponsors and Partners
Elite Members and Partnerships
The Value of Membership
How to Get Involved
Join BioUtah
Join BioUtah
About Membership
Standard Membership Levels
Why Join? Who Should Join?
Member Spotlight
Membership Directory
Utah Life Sciences News
National Life Sciences News
Why Utah?
Interviews with Utah Life Sciences Leaders
Resources
Utah Life Sciences Industry Reports
Workforce
“Invest in You Too”
Medical Innovations Pathways
MENU
MENU
About
BioUtah Mission-Vision
Our Team
Governance
Board of Directors
Advisory Board
Elite Members
Partnerships
Membership
Member Login
Why BioUtah?
Member Deals
Apply for Membership
Membership Directory
Advocacy
News/Events
Events
Life Sciences News
Podcasts
Why Utah?
Life Sciences Report
Life Sciences Leadership
Investment
Newsletter
BioHive
Join Now
Utah Life Sciences News & Events
advocacy
August 21, 2019
Recent News
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology
Xenter Closes Series A at $12M; Adds Four Additional Board Members
Who Develops Medicines? A New Study Highlights Role of Private Investment
IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO